Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cholera Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global cholera vaccines market reached a value of US$ 4.36 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 8.63 Million by 2027, exhibiting a CAGR of 11.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Cholera is an intestinal disease caused by bacterial infections that spread through contaminated food and water. It leads to severe diarrhea, dehydration, abdominal pain, fever, rapid heart rate, loss of skin elasticity, low blood pressure, muscle cramps, and dry mucous membranes, such as the inside of the mouth, throat, nose, and eyelids. It is presently a global threat to public health, which can be prevented through the vaccine. The cholera vaccine exposes a small dose of live cholera bacteria in the body that helps develop immunity against the disease. It can be given orally or injected intradermally or intramuscularly in the body.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Cholera Vaccines Market Trends:

The growing prevalence of cholera on account of poor hygiene and sanitation represents one of the major factors driving the market. In addition, there is a rise in the use of contaminated water for agriculture and olericulture across the globe. This, along with the increasing consumption of street and fast food due to the hectic lifestyles of individuals, is propelling the growth of the market. Moreover, there is a considerable rise in water pollution on account of sewage and factory wastes getting discharged into lakes and rivers. As a result, people are consuming contaminated seafood worldwide, which, in turn, is resulting in the spread of cholera. Additionally, rising awareness about cholera through initiatives of non-governmental organizations (NGOs), along with numerous immunization programs introduced by governments of several countries to reduce vaccine-preventable diseases, is positively influencing the market. Furthermore, key market players are extensively investing in research and development (R&D) activities to provide more efficient and cost-effective cholera vaccines, which is projected to propel the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cholera vaccines market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on vaccine type, product and end user.

Breakup by Vaccine Type:

  • Whole Cell V. Cholerae O1 with Recombinant B-Subunit
  • Killed Oral O1 and O139
     

Breakup by Product:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Dukoral
  • Shanchol
  • Vaxchora
  • Euvichol and Euvichol-Plus
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Research and Academic Laboratories
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.), Emergent BioSolutions Inc., Eubiologics Co. Ltd., Johnson & Johnson, Merck & Co. Inc, Pfizer Inc., PharmaChoice Canada Inc, Sanofi S.A., Takeda Pharmaceutical Company Limited and Valneva SE.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Million
Segment Coverage Vaccine Type, Product, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Astellas Pharma Inc., Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.), Emergent BioSolutions Inc., Eubiologics Co. Ltd., Johnson & Johnson, Merck & Co. Inc, Pfizer Inc., PharmaChoice Canada Inc, Sanofi S.A., Takeda Pharmaceutical Company Limited and Valneva SE.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global cholera vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cholera vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cholera vaccines market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Cholera Vaccines Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Vaccine Type
    6.1    Whole Cell V. Cholerae O1 with Recombinant B-Subunit
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Killed Oral O1 and O139
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Product
    7.1    Dukoral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Shanchol
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Vaxchora
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Euvichol and Euvichol-Plus
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by End User
    8.1    Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Research and Academic Laboratories
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Astellas Pharma Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Emergent BioSolutions Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Eubiologics Co. Ltd.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    Johnson & Johnson
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Merck & Co. Inc
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Pfizer Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    PharmaChoice Canada Inc
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Sanofi S.A.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Takeda Pharmaceutical Company Limited.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Valneva SE
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials

List of Figures

Figure 1: Global: Cholera Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Cholera Vaccines Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Cholera Vaccines Market: Breakup by Vaccine Type (in %), 2021
Figure 5: Global: Cholera Vaccines Market: Breakup by Product (in %), 2021
Figure 6: Global: Cholera Vaccines Market: Breakup by End User (in %), 2021
Figure 7: Global: Cholera Vaccines Market: Breakup by Region (in %), 2021
Figure 8: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Cholera Vaccines (Killed Oral O1 and O139) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Cholera Vaccines (Killed Oral O1 and O139) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Cholera Vaccines (Dukoral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Cholera Vaccines (Dukoral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Cholera Vaccines (Shanchol) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Cholera Vaccines (Shanchol) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Cholera Vaccines (Vaxchora) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Cholera Vaccines (Vaxchora) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Cholera Vaccines (Other Product) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Cholera Vaccines (Other Product) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Cholera Vaccines (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Cholera Vaccines (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Cholera Vaccines (Research and Academic Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Cholera Vaccines (Research and Academic Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Cholera Vaccines (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Cholera Vaccines (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Cholera Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Cholera Vaccines Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Cholera Vaccines Industry: SWOT Analysis
Figure 78: Global: Cholera Vaccines Industry: Value Chain Analysis
Figure 79: Global: Cholera Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cholera Vaccines Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cholera Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2022-2027
Table 3: Global: Cholera Vaccines Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 4: Global: Cholera Vaccines Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Cholera Vaccines Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Cholera Vaccines Market: Competitive Structure
Table 7: Global: Cholera Vaccines Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links